Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy.
Kyungchan MinJae Wook ChungYun Sok HaJun Nyung LeeBum Soo KimHyun Tae KimTae Hwan KimEun Sang YooTae Gyun KwonSung Kwang ChungMasatoshi TanakaShin EgawaTakahiro KimuraSeock Hwan ChoiPublished in: The world journal of men's health (2019)
Concurrent DTX-based chemotherapy and ADT may be beneficial compared with DTX-based chemotherapy alone in chemotherapy-naïve metastatic CRPC patients in terms of the PFS, but not the OS.